• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.

作者信息

Tranum B L, McDonald B, Thigpen T, Vaughn C, Wilson H, Maloney T, Costanzi J, Bickers J, el Mawli N G, Palmer R, Hoogstraten B, Heilburn L, Rasmusen S

出版信息

Cancer. 1982 Mar 1;49(5):835-9. doi: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z.

DOI:10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z
PMID:7037152
Abstract
摘要

相似文献

1
Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Cancer. 1982 Mar 1;49(5):835-9. doi: 10.1002/1097-0142(19820301)49:5<835::aid-cncr2820490502>3.0.co;2-z.
2
Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).晚期乳腺癌的化疗：长春新碱、阿霉素和环磷酰胺（VAC）与环磷酰胺、甲氨蝶呤、5-氟尿嘧啶和泼尼松（CMFP）的随机试验。
Cancer. 1981 Oct 1;48(7):1517-21. doi: 10.1002/1097-0142(19811001)48:7<1517::aid-cncr2820480707>3.0.co;2-8.
3
Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
Am J Clin Oncol. 1983 Feb;6(1):1-18.
4
Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.晚期乳腺癌单药与联合细胞毒性化疗的随机研究
Eur J Cancer (1965). 1980 Dec;16(12):1621-5. doi: 10.1016/0014-2964(80)90037-7.
5
Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
Cancer. 1978 Nov;42(5):2141-8. doi: 10.1002/1097-0142(197811)42:5<2141::aid-cncr2820420509>3.0.co;2-3.
6
A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.晚期乳腺癌患者中，环磷酰胺、阿霉素和5-氟尿嘧啶（CAF）与环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松（CMFVP）的比较。
Breast Cancer Res Treat. 1983;3(2):209-20. doi: 10.1007/BF01803563.
7
[Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].[采用两种连续化疗方案治疗晚期乳腺癌]
Medicina (B Aires). 1982;42(6 Pt 1):587-95.
8
Adjuvant chemotherapy for breast cancer. Implications of clinical trials.
Postgrad Med. 1985 Jan;77(1):75-7, 80-3. doi: 10.1080/00325481.1985.11698840.
9
Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
Clin Oncol. 1980 Jun;6(2):153-7.
10
Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.阿霉素、长春新碱、环磷酰胺和5-氟尿嘧啶（AVCF）与环磷酰胺、甲氨蝶呤和5-氟尿嘧啶（CMF）在绝经前乳腺癌中的比较。个人研究结果。
Drugs Exp Clin Res. 1986;12(1-3):143-5.

引用本文的文献

1
Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer.S-1与曲妥珠单抗联合治疗人表皮生长因子受体2阳性转移性或复发性乳腺癌患者的可行性及药代动力学
Int J Clin Oncol. 2014 Apr;19(2):274-9. doi: 10.1007/s10147-013-0547-4. Epub 2013 Apr 5.
2
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.在转移性乳腺癌化疗方案中添加药物。
Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003368. doi: 10.1002/14651858.CD003368.pub3.
3
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).
新辅助多柔比星治疗后行乳房切除术，随后辅助环磷酰胺、甲氨蝶呤和氟尿嘧啶（CMF）治疗，再行放疗，针对III期乳腺癌的15年中位随访结果：一项II期试验（CALGB 8944）
Breast Cancer Res Treat. 2009 Feb;113(3):479-90. doi: 10.1007/s10549-008-9943-2. Epub 2008 Feb 28.
4
Hepatic arterial infusion chemotherapy for liver metastases from breast cancer.乳腺癌肝转移的肝动脉灌注化疗
Cancer Chemother Pharmacol. 1994;33 Suppl:S142-4. doi: 10.1007/BF00686687.
5
Chemotherapy of breast cancer.乳腺癌的化疗
Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.
6
Current status of chemotherapy of breast cancer.乳腺癌化疗的现状
Drugs. 1984 Aug;28(2):93-8. doi: 10.2165/00003495-198428020-00001.
7
Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancer.辅助化疗失败对接受复发性乳腺癌连续化疗的女性预后的可能不良影响。
J Cancer Res Clin Oncol. 1987;113(5):488-94. doi: 10.1007/BF00390044.
8
Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.5-氟尿嘧啶、口服伊达比星和环磷酰胺联合化疗（FIC）治疗转移性乳腺癌——一项开放性II期研究。
J Cancer Res Clin Oncol. 1988;114(3):301-5. doi: 10.1007/BF00405838.
9
Short term high density systemic therapy for metastatic breast cancer.转移性乳腺癌的短期高密度全身治疗
Breast Cancer Res Treat. 1985;5(2):177-88. doi: 10.1007/BF01805992.
10
High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study.大剂量表柔比星作为晚期乳腺癌的一线化疗：一项II期研究。
Cancer Chemother Pharmacol. 1991;27(5):394-6. doi: 10.1007/BF00688864.